Congratulations to the RVX team.

This reinforces my perception that lots is going on that we can't see (and it's not all summer vacation...haha...egg on my face).

FDA approval should;

1. Cause BP and other suitors to take notice and give this company some attention.
2. Increase interest from analysts.
3. Enhance financing possibilities.
4. If Don and Co. have been in negotiations with another partner beyond Hepalink it should enhance the value proposition for RVX and perhaps attract the attention of other potential partners.
5. FDA approval could possibly lead to trails in Canada.
6. Make it easier for other USA based trials for Appabetalone.

Great news. Perhaps we'll see some other important chess moves in this game soon. The momentum is building.

Toinv